MEDIKIT CO.,LTD. (7749.T) Financial Statements

Income statement

Metric	TTM	2026	2025	2024	2023
Revenue
Total Revenue	23.7B	23.8B	22.6B	21.9B	21.6B
Cost of Revenue	3.7B	14.8B	13.9B	13.1B	13.3B
Gross Profit	2.2B	9.0B	8.7B	8.8B	8.3B
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	1.2B	4.7B	4.2B	4.1B	4.2B
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	—	—	—	—	—
Total Operating Expenses	1.2B	4.7B	4.2B	4.1B	4.2B
Cost and Expenses	19.2B	19.5B	18.1B	17.2B	17.5B
Operating Income (EBIT)	4.5B	4.3B	4.5B	4.7B	4.1B
Non-Operating
Interest Income	5.4M	46.4M	15.4M	4.4M	3.4M
Interest Expense	1.9M	7.7M	7.6M	7.6M	7.5M
Net Interest Income	3.5M	38.7M	7.9M	(3.2M)	(4.2M)
Other Non-Op Income/Expense	46.0M	211.8M	171.7M	103.8M	59.5M
Non-Operating Income (excl Interest)	44.8M	188.6M	182.0M	191.4M	121.3M
EBT (Pre-Tax Income)	1.1B	4.5B	4.7B	4.8B	4.3B
Income Tax Expense	702.7M	1.5B	1.6B	1.7B	1.4B
Bottom Line
Net Income	3.1B	3.0B	3.0B	3.1B	2.9B
Earnings from Cont. Ops	—	—	—	—	—
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	3.1B	3.0B	3.0B	3.1B	2.9B
Per Share
Basic EPS	¥211	¥206	¥205	¥188	¥171
Diluted EPS	¥211	¥206	—	—	—
Revenue Per Share	¥1,622	¥1,633	¥1,531	¥1,338	¥1,287
Shares
Basic Shares Outstanding	14.6M	14.6M	14.7M	16.3M	16.8M
Diluted Shares Outstanding	—	—	—	—	—
Profitability Metrics
EBITDA	—	6.1B	6.0B	6.0B	5.4B
D&A	—	1.8B	1.5B	1.3B	1.3B
EBIT	4.5B	4.3B	4.5B	4.7B	4.1B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026